Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Breast Neoplasms 139Neoplasms 118Prostatic Neoplasms 64Lung Neoplasms 48Head and Neck Neoplasms 46Colorectal Neoplasms 38Ovarian Neoplasms 33Uterine Cervical Neoplasms 29Endometrial Neoplasms 23Motor Activity 22Neoplasm Metastasis 20Multiple Myeloma 20Pancreatic Neoplasms 19Brain Neoplasms 19Rectal Neoplasms 18Lymphoma 17Colonic Neoplasms 17Pain 16Gastrointestinal Neoplasms 16Fatigue 16Carcinoma, Non-Small-Cell Lung 16Leukemia 15Depression 15Oropharyngeal Neoplasms 13Melanoma 13Anxiety Disorders 13Urinary Bladder Neoplasms 12Hematologic Neoplasms 12Esophageal Neoplasms 12Stomach Neoplasms 11

Interventions

fludarabine phosphate 25Cyclophosphamide 24Peripheral Blood Stem Cell Transplantation 23Busulfan 17Tacrolimus 15Methotrexate 13Cyclosporine 13ruxolitinib 12Whole-Body Irradiation 12Mycophenolic Acid 12Antilymphocyte Serum 11Filgrastim 8Decitabine 7fludarabine 6Etoposide 611-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 6peginterferon alfa-2a 5Radiotherapy 5Methylprednisolone 5Cytarabine 5Carboplatin 5Prednisone 4Melphalan 4Flow Cytometry 4Biopsy 4Aspirin 4givinostat hydrochloride 3givinostat 3bomedemstat 3anagrelide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocythemia, Essential × Surveys and Questionnaires × Clear all
NCT02410551 2018-10-30

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡